Cardiologists and researchers attending a conference in Washington, DC, on March 5 largely backed recent research showing that devices coated with a specific drug may lead to increased mortality in peripheral artery disease (PAD) patients. But there was little agreement as to what causes might lie behind the apparent risk.
An all-day town hall on the safety of drug-coated balloons (DCBs) and drug-eluting stents (DESs) was held at the Cardiovascular...